文献速递关节外科创伤骨科

胫距跟融合术结局的影响因素分析

Factors affecting the outcomes of tibiotalocalcaneal fusion.
PubMed 文献 · Bone Joint J · 2020-01-01

该回顾性研究纳入101例2011至2019年行胫距跟融合术的患者,分析术前情况与术后并发症的关系。结果显示Charcot关节病和非创伤性骨关节炎患者的不愈合率及感染率显著高于创伤性关节炎,糖尿病、慢性肾病及年龄>60岁分别增加不愈合或感染风险,自体骨移植可能降低感染率。

要点

  • Charcot关节病和非创伤性骨关节炎患者TTC融合术后不愈合和感染风险显著高于创伤性关节炎。
  • 糖尿病和慢性肾病患者不愈合风险增加,年龄>60岁患者术后感染风险增加。
  • 自体骨移植可能降低术后感染风险。

核心结论

  • TTC融合术后并发症发生率仍较高,Charcot关节病或非创伤性关节病患者不愈合及感染风险高于创伤性关节炎患者。
  • 糖尿病、慢性肾病或年龄>60岁患者不愈合风险增加,自体骨移植可能有助于降低感染率。

研究设计与样本

  • 回顾性分析2011至2019年同一机构101例接受TTC融合术患者的病历资料。
  • 分析年龄、性别、糖尿病、心血管疾病、吸烟、术前踝关节畸形及术中骨移植使用与术后并发症的风险比(RR)。

主要发现

  • 101例中29例(28.7%)不愈合,5例(4.9%)行膝下截肢,40例(39.6%)重返手术室,16例(15.8%)内固定失败,22例(21.8%)术后感染。
  • Charcot关节病患者不愈合率44.4%(12例)、感染率29.6%(8例),非创伤性骨关节炎患者不愈合率39.1%(18例)、感染率37%(17例),均显著高于创伤性关节炎(p=0.016和p=0.002)。
  • 糖尿病患者不愈合率显著增高(RR 2.22;p=0.010),慢性肾病患者不愈合风险增加2.37倍(p=0.006)。
  • 年龄>60岁患者术后感染风险增加三倍以上(RR 3.60;p=0.006),使用骨移植对术后感染有显著保护作用(p=0.019)。

关键数值与推荐

  • Charcot关节病与非创伤性骨关节炎患者不愈合率分别为44.4%和39.1%,感染率分别为29.6%和37%,显著高于创伤性关节炎(p=0.016和p=0.002)。
  • 糖尿病患者不愈合风险比RR 2.22(p=0.010),慢性肾病患者不愈合风险比RR 2.37(p=0.006)。
  • 年龄>60岁患者术后感染风险比RR 3.60(p=0.006),使用骨移植对术后感染有显著保护作用(p=0.019)。

临床怎么用

  • 术前应评估Charcot关节病、非创伤性骨关节炎、糖尿病、慢性肾病及年龄>60岁等高危因素,用于患者咨询和手术规划。
  • 对高危患者可考虑使用自体骨移植以降低术后感染风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Tibiotalocalcaneal (TTC) fusion is used to treat a variety of conditions affecting the ankle and subtalar joint, including osteoarthritis (OA), Charcot arthropathy, avascular necrosis (AVN) of the talus, failed total ankle arthroplasty, and severe deformity. The prevalence of postoperative complications remains high due to the complexity of hindfoot disease seen in these patients. The aim of this study was to analyze the relationship between preoperative conditions and postoperative complications in order to predict the outcome following primary TTC fusion. METHODS: We retrospectively reviewed the medical records of 101 patients who underwent TTC fusion at the same institution between 2011 and 2019. Risk ratios (RRs) associated with age, sex, diabetes, cardiovascular disease, smoking, preoperative ankle deformity, and the use of bone graft during surgery were related to the postoperative complications. We determined from these data which pre- and perioperative factors significantly affected the outcome. RESULTS: Out of the 101 patients included in the study, 29 (28.7%) had nonunion, five (4.9%) required below-knee amputation (BKA), 40 (39.6%) returned to the operating theatre, 16 (15.8%) had hardware failure, and 22 (21.8%) had a postoperative infection. Patients with a preoperative diagnosis of Charcot arthropathy and non-traumatic OA had significantly higher nonunion rates of 44.4% (12 patients) and 39.1% (18 patients) (p = 0.016) and infection rates of 29.6% (eight patients) and 37% (17 patients) compared to patients with traumatic arthritis, respectively (p = 0.002). There was a significantly increased rate of nonunion in diabetic patients (RR 2.22; p = 0.010). Patients with chronic kidney disease were 2.37-times more likely to have a nonunion (p = 0.006). Patients aged over 60 years had more than a three-fold increase in the rate of postoperative infection (RR 3.60; p = 0.006). The use of bone graft appeared to be significantly protective against postoperative infection (p = 0.019). CONCLUSION: We were able to confirm, in the largest series of TTC ankle fusions currently in the literature, that there remains a high rate of complications following this procedure. We found that patients with a Charcot or non-traumatic arthropathy had an increased risk of nonunion and postoperative infection compared to individuals with traumatic arthritis. Those with diabetes, chronic kidney disease, or aged over 60 years had an increased risk of nonunion. These findings help to confirm those of previous studies. Additionally, our study adds to the literature by showing that autologous bone graft may help in decreasing infection rates. These data can be useful to surgeons and patients when considering, discussing and planning TTC fusion. It helps surgeons further understand which patients are at a higher risk for postoperative complications when undergoing TTC fusion. Cite this article: Bone Joint J. 2020;102-B(3):345-351.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Pitts C, Alexander B, Washington J, et al. Factors affecting the outcomes of tibiotalocalcaneal fusion. Bone Joint J. 2020. PMID: 32114814. doi:10.1302/0301-620X.102B3.BJJ-2019-1325.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。